Physician profile
Sergio Rubinstein
NPI 1316227655
$8,492.45
in general payments reported to CMS, 2019-2025
12 companies · $214 in 2025
The $214 reported for 2025 was more than what 77% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,141 · 2021: $1,732 · 2022: $130 · 2023: $160 · 2024: $1,116 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,071 · Food and Beverage: $367 · Gift: $51.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,071.33 |
| Food and Beverage | $367.45 |
| Gift | $51.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Ih INC. | $4,040.12 | 2019-2021 | |
| Dentsply Sirona INC | $2,595.08 | 2019-2024 | Astra Tech Implant System |
| Kuraray America INC. | $1,071.33 | 2024 | |
| Align Technology, INC. | $200.16 | 2025 | Invisalign |
| Biohorizons Implant Systems INC. | $156.77 | 2022-2025 | Biohorizons, Biohorizons Dental Implants |
| Ultradent Products INC | $152.49 | 2021 | |
| Thommen Medical USA, LLC | $74.33 | 2022 | |
| Zimmer Biomet Holdings, INC. | $71.71 | 2019 | |
| Straumann USA LLC | $51.00 | 2023 | |
| Nobel Biocare USA | $45.04 | 2019 | |
| 3m Company | $19.64 | 2019 | |
| Gc America INC. | $14.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergio Rubinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.